TY - JOUR
T1 - Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction
AU - Cotton, Peter B.
AU - Durkalski, Valerie
AU - Orrell, Kyle B.
AU - Brawman-Mintzer, Olga
AU - Drossman, Douglas A.
AU - Wilcox, C. Mel
AU - Mauldin, Patrick D.
AU - Elta, Grace H.
AU - Tarnasky, Paul R.
AU - Fogel, Evan L.
AU - Jagganath, Sanjay B.
AU - Kozarek, Richard A.
AU - Freeman, Martin L.
AU - Romagnuolo, Joseph
AU - Robuck, Patricia R.
PY - 2010/11
Y1 - 2010/11
N2 - Background Sphincter of Oddi dysfunction (SOD) is a controversial topic, especially in patients with no objective findings on laboratory or imaging studies (SOD type III). The value of ERCP manometry with sphincterotomy is unproven and carries significant risks. Objective To describe the process of planning and initiating a randomized sham-controlled study to establish whether patients with SOD respond to sphincter ablation, and whether the outcomes are predicted by the pain patterns, presence or absence of other functional GI or psychosocial problems, or the results of manometry. Design Planning a trial to establish which patients with "suspected SOD" (if any) respond to endoscopic sphincter ablation. Setting Meetings and correspondence by a planning group of gastroenterologists and clinical research specialists hosted at the Medical University of South Carolina. Patients Clarifying subject characteristics and inclusion and exclusion criteria. Interventions Defining the questionnaires, therapies, randomizations, and numbers of subjects required by outcome measures. Defining the metrics of success and failure. Results The planning resulted in funding for the proposed study as a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases. Limitations Lack of data required several consensus decisions in designing the protocol. Conclusion The planning process was challenging, and some changes were needed after initiation. (Clinical trial registration number: NCT00688662.)
AB - Background Sphincter of Oddi dysfunction (SOD) is a controversial topic, especially in patients with no objective findings on laboratory or imaging studies (SOD type III). The value of ERCP manometry with sphincterotomy is unproven and carries significant risks. Objective To describe the process of planning and initiating a randomized sham-controlled study to establish whether patients with SOD respond to sphincter ablation, and whether the outcomes are predicted by the pain patterns, presence or absence of other functional GI or psychosocial problems, or the results of manometry. Design Planning a trial to establish which patients with "suspected SOD" (if any) respond to endoscopic sphincter ablation. Setting Meetings and correspondence by a planning group of gastroenterologists and clinical research specialists hosted at the Medical University of South Carolina. Patients Clarifying subject characteristics and inclusion and exclusion criteria. Interventions Defining the questionnaires, therapies, randomizations, and numbers of subjects required by outcome measures. Defining the metrics of success and failure. Results The planning resulted in funding for the proposed study as a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases. Limitations Lack of data required several consensus decisions in designing the protocol. Conclusion The planning process was challenging, and some changes were needed after initiation. (Clinical trial registration number: NCT00688662.)
UR - http://www.scopus.com/inward/record.url?scp=78049350725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049350725&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2010.08.022
DO - 10.1016/j.gie.2010.08.022
M3 - Article
C2 - 21034899
AN - SCOPUS:78049350725
SN - 0016-5107
VL - 72
SP - 986
EP - 991
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 5
ER -